Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

GSK Investigational Site, Sofia

GSK Investigational Site, Budapest

GSK Investigational Site, Budapest

GSK Investigational Site, Brussels

GSK Investigational Site, Budapest

GSK Investigational Site, Brussels

GSK Investigational Site, Sofia

GSK Investigational Site, Sofia

GSK Investigational Site, St Leonards

GSK Investigational Site, Liverpool

GSK Investigational Site, Gosford NSW

GSK Investigational Site, Edegem

GSK Investigational Site, Fitzroy

GSK Investigational Site, Clayton

GSK Investigational Site, Geelong

GSK Investigational Site, Plovdiv

GSK Investigational Site, Debrecen

GSK Investigational Site, Nyíregyháza

GSK Investigational Site, Woodville

GSK Investigational Site, Yvoir

GSK Investigational Site, Pleven

GSK Investigational Site, Nedlands

GSK Investigational Site, Hobart

GSK Investigational Site, Kaposvár

GSK Investigational Site, Bruges

GSK Investigational Site, Kortrijk

GSK Investigational Site, Gyeonggi-do

GSK Investigational Site, Athens

GSK Investigational Site, Clifton Park

GSK Investigational Site, Haidari - Athens

GSK Investigational Site, Berlin

GSK Investigational Site, Seongnam-si Gyeonggi-do

GSK Investigational Site, Santiago de Compostela

GSK Investigational Site, Milan

GSK Investigational Site, Milan

GSK Investigational Site, Incheon

GSK Investigational Site, Brescia

GSK Investigational Site, Pátrai

GSK Investigational Site, Pavia

GSK Investigational Site, Pozuelo de AlarcOn Madr

GSK Investigational Site, Málaga

GSK Investigational Site, Krakow

GSK Investigational Site, PamplonaNavarra

GSK Investigational Site, Montpellier

GSK Investigational Site, Bologna

GSK Investigational Site, Cincinnati

GSK Investigational Site, Ravenna

GSK Investigational Site, Detroit

GSK Investigational Site, Siena

GSK Investigational Site, Milwaukee

GSK Investigational Site, Thessaloniki

GSK Investigational Site, Thessaloniki

GSK Investigational Site, Hwasun

GSK Investigational Site, San Giovanni Rotondo FG

GSK Investigational Site, Le Mans

GSK Investigational Site, Tübingen

GSK Investigational Site, Tyler

GSK Investigational Site, Pueblo

GSK Investigational Site, Tucson

GSK Investigational Site, Poitiers

GSK Investigational Site, Catanzaro

GSK Investigational Site, Corvallis

GSK Investigational Site, Eugene

GSK Investigational Site, Beijing

GSK Investigational Site, Beijing

GSK Investigational Site, Beijing

GSK Investigational Site, Beijing

GSK Investigational Site, Changsha

GSK Investigational Site, Syktyvkar

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Saint Petersburg

GSK Investigational Site, Xuzhou

GSK Investigational Site, Kaluga

GSK Investigational Site, Tianjin

GSK Investigational Site, Tula

GSK Investigational Site, Tianjin

GSK Investigational Site, Hangzhou

GSK Investigational Site, Nanchang

GSK Investigational Site, Sochi

GSK Investigational Site, Samara

GSK Investigational Site, Zhengzhou

GSK Investigational Site, Guangzhou

GSK Investigational Site, Shenzhen

GSK Investigational Site, Nizhny Novgorod

GSK Investigational Site, Kirov

GSK Investigational Site, Chengdu

GSK Investigational Site, Yekaterinburg

GSK Investigational Site, Novosibirsk

GSK Investigational Site, Krasnoyarsk

GSK Investigational Site, Albany

GSK Investigational Site, St Albans

GSK Investigational Site, Porto Alegre

GSK Investigational Site, Curitiba

GSK Investigational Site, Fortaleza

GSK Investigational Site, Porto Alegre

GSK Investigational Site, Rio de Janeiro

GSK Investigational Site, São Paulo

GSK Investigational Site, São Paulo

GSK Investigational Site, São Paulo

GSK Investigational Site, São Paulo

GSK Investigational Site, Sofia

GSK Investigational Site, Edmonton

GSK Investigational Site, Athens

GSK Investigational Site, Larissa

GSK Investigational Site, Perugia

GSK Investigational Site, Roma

GSK Investigational Site, Aichi

GSK Investigational Site, Chiba

GSK Investigational Site, Ehime

GSK Investigational Site, Fukushima

GSK Investigational Site, Gifu

GSK Investigational Site, Gunma

GSK Investigational Site, Hokkaido

GSK Investigational Site, Kyoto

GSK Investigational Site, Kyoto

GSK Investigational Site, Osaka

GSK Investigational Site, Tokyo

GSK Investigational Site, Tokyo

GSK Investigational Site, Amersfoort

GSK Investigational Site, Gdansk

GSK Investigational Site, Torun

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Barcelona

GSK Investigational Site, Barcelona

GSK Investigational Site, L'Hospitalet de Llobrega

GSK Investigational Site, Airdrie

GSK Investigational Site, Dundee

GSK Investigational Site, Edinburgh

GSK Investigational Site, London

GSK Investigational Site, London

GSK Investigational Site, Nottingham

GSK Investigational Site, Oxford

GSK Investigational Site, Plymouth

GSK Investigational Site, Stoke-on-Trent